<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>18</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2017</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Enhancing Effects of Curcumin on Cytotoxicity of Paclitaxel, Methotrexate and Vincristine in Gastric Cancer Cells</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>65</FirstPage>
			<LastPage>68</LastPage>
			<ELocationID EIdType="pii">43090</ELocationID>
			
<ELocationID EIdType="doi">10.22034/APJCP.2017.18.1.65</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Meysam </FirstName>
					<LastName>Ebrahimifar</LastName>
<Affiliation>Department of Toxicology, Faculty of Pharmacy, Islamic Azad
University, Shahreza Branch, Shahreza</Affiliation>

</Author>
<Author>
					<FirstName>Majid </FirstName>
					<LastName>Hasanzadegan Roudsari</LastName>
<Affiliation>Department of chemical Engineering, Science and Research branch, Islamic Azad University, Tehran, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>S Maryam </FirstName>
					<LastName>Kazemi</LastName>
<Affiliation>Department of Genetics, Islamic Azad University, Tehran Medical Branch, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hasan </FirstName>
					<LastName>Ebrahimi Shahmabadi</LastName>
<Affiliation>Department of Microbiology, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Leila </FirstName>
					<LastName>Kanaani</LastName>
<Affiliation>Department of Toxicology, Faculty of Pharmacy, Islamic Azad
University, Shahreza Branch, Shahreza</Affiliation>

</Author>
<Author>
					<FirstName>S.A. </FirstName>
					<LastName>Alavi</LastName>
<Affiliation>Hakiman-e-Shargh Investigative Corporation, Isfahan Science and Technology Town, Isfahan, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mehdi </FirstName>
					<LastName>Izadi Vasfi</LastName>
<Affiliation>Department of Chemical Engineering, Faculty of Pharmacy, Islamic Azad University, Shahreza, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2016</Year>
					<Month>09</Month>
					<Day>20</Day>
				</PubDate>
			</History>
		<Abstract> &lt;br /&gt; &lt;span style=&quot;font-size: small;&quot;&gt;Curcumin (Diferuloylmethane), a polyphenolic compound with antioxidant, anti-inflammatory and anticancer &lt;/span&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;properties, has been found to increase chemotherapeutic agents-induced cytotoxicity in some resistant cancer cell &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size: small;&quot;&gt;lines. This investigation aimed to study the effects of curcumin on efficacy of some common anticancer agents in &lt;/span&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;gastric cancer cells. AGS cells were cultured in RPMI-1640 medium under standard culture conditions (5% CO2 and &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size: small;&quot;&gt;95% humidified air at 37°C). Curcumin was used at concentrations of 5, 15, 30 and 50 μM. Cells were treated with a combination of curcumin and paclitaxel (300 nm) or methotrexate (100 μm) or vincristine (5 nm). Cell viability, the &lt;/span&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;percentage of live cells in the whole population, was evaluated by MTT assay after 48 hours. The results showed that &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;font-size: small;&quot;&gt;cell viability was significantly decreased after incubation of AGS cells with curcumin. Combination with curcumin (15-50 μm) significantly increased cytotoxicity of all three agents (P&lt;0.001). Regarding high anticancer potential and &lt;/span&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;&lt;span style=&quot;font-family: Times New Roman,Times New Roman; font-size: small;&quot;&gt;enhancement of chemotherapeutic agent-induced cytotoxicity, the combined use of curcumin with standard chemotherapy of gastric cancer is suggested as a strategy for better management of this fatal cancer. &lt;/span&gt;&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">curcumin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Gastric cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Chemotherapy</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_43090_6d1566ef8145ed2d812776822ff02094.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
